Clinical Research Lead-Oncology

Chester, Maryland, United States

Apply with AI Apply

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, Pharmaceuticals, BiotechnologyIndustries

Requirements

Candidates must possess deep therapeutic and scientific knowledge, combined with strategic agility to influence investigators and elevate protocol understanding. A proven ability to develop and sustain high-trust relationships with investigators is essential. Advanced understanding of local treatment paradigms and standard of care is required.

Responsibilities

The Clinical Research Lead will drive the execution of clinical trials through exceptional investigator engagement and site performance management. They will serve as a scientific ambassador, ensuring investigators understand protocol intent and scientific rationale. Responsibilities include influencing enrollment by co-creating tailored recruitment strategies, capturing and elevating critical insights from sites, leading site-level strategy and risk planning, and driving inspection readiness across sites. The role also involves collaborating across functions and with vendor partners to resolve operational barriers and providing oversight for vendor monitoring.

Skills

Clinical trial execution

Investigator engagement

Site performance management

Therapeutic knowledge

Scientific knowledge

Protocol understanding

Enrollment strategies

Clinical development

Medical affairs

Regulatory affairs

External affairs

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free